Strongyloidiasis Treatment Outcomes: A Prospective Study Using Serological and Molecular Methods

Ana Lucas Dato1,2, Philip Wikman-Jorgensen2,3,4, José María Saugar Cruz5,6

  • 1Internal Medicine/Infectious Diseases Department, Vega Baja Hospital-Orihuela, 03314 Alicante, Spain.

Summary

Ivermectin effectively treats chronic strongyloidiasis in over 90% of patients. This study highlights its efficacy for Strongyloides stercoralis infection, with PCR aiding in detecting persistent cases.